New and Evolving Therapeutic Targets in Lung Cancer: Expert Guidance in Incorporating Biomarker Testing to Deliver Precision Therapy

Gain expert insights on how to test for new and emerging molecular targets and incorporate targeted agents into the care of your patients with lung cancer with downloadable slides and on-demand Webcasts from live meetings biomarker summary handouts and a decision support tool providing the latest individualized guidance on precision therapy for NSCLC.

Share

Program Content

Activities

FAQ: Biomarker Testing/Targeted Tx
Precision Therapy in Lung Cancer: FAQ on Biomarker Testing and Targeted Therapies
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: August 10, 2020

FAQ: ICI Biomarkers
Precision Therapy in Lung Cancer: FAQ on Biomarkers for Immune Checkpoint Inhibitors
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: August 10, 2020

ESMO 2020: NSCLC
Practical Insights on Key Data From ESMO 2020 Informing Precision Medicine in NSCLC
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: December 21, 2020

NSCLC Biomarkers: Pathology Q&A
Expert Answers to Pathologist Questions on New Biomarkers for Precision Therapy in Lung Cancer
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: December 28, 2020

Activities

Biomarkers in NSCLC: Podcast Pearls
Biomarker Testing and Targeted Therapies in NSCLC: Podcast Pearls
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: August 10, 2020

ICI Biomarkers in NSCLC: Podcast Pearls
Biomarker Testing and Immune Checkpoint Inhibitors in NSCLC: Podcast Pearls
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: August 10, 2020

ESMO 2020 NSCLC: Podcast Pearls
Data From ESMO 2020 Informing Precision Medicine in NSCLC: Podcast Pearls
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 21, 2020

NSCLC Biomarkers for Pathologists: Podcast Pearls
New Biomarkers for Precision Therapy in Lung Cancer: Podcast Pearls
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 29, 2020

Activities

Lung Biomarkers
An Overview of Biomarkers Essential for Precision Therapy in Lung Cancer
Congratulations: You achieved a completion on 04/09/2022
New Biomarkers in Lung Cancer
The New Biomarkers Pathologists Need to Know for Precision Therapy in Lung Cancer
Congratulations: You achieved a completion on 04/09/2022

Activities

Lung Cancer Biomarkers
Practical Insights on Evolving Biomarkers for Precision Therapy in Lung Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 05, 2020

<i>EP</i>: Lung Biomarkers
ExpressPoints: Practical Insights on Evolving Biomarkers for Precision Therapy in Lung Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 29, 2020

New Biomarkers in NSCLC
New Predictive Biomarkers and Therapeutic Targets Poised to Change Lung Cancer Care
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 25, 2020

IO Biomarkers in NSCLC
Evolving Understanding of Biomarkers of Response to Immune Checkpoint Inhibition in NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 25, 2020

<i>EP</i>: New Biomarkers in NSCLC
ExpressPoints: The New Biomarkers Oncologists Need To Know for Precision Therapy in Lung Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 26, 2020

Overview Lung Cancer Biomarkers
The Why and Who: Overview of Newly Available and Emerging Biomarkers in Lung Cancer Therapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 12, 2020

Biomarker Testing in Lung Cancer
The How: Evidence-Based Testing Strategies to Detect Appropriate Gene Alterations
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 12, 2020

Lung Biomarkers EP
ExpressPoints: The New Biomarkers Pathologists Need to Know for Precision Therapy in Lung Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 24, 2020

Activities

NSCLC Biomarkers 2020
New Developments in NSCLC Targeted Therapy: Where We Are Heading in 2020
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 28, 2020

CNS Mets in NSCLC
How I Manage CNS Metastases and Leptomeningeal Carcinomatosis in NSCLC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 28, 2020

Selpercatinib in <i>RET</i>+ NSCLC
My Take on the Recent Approval of Selpercatinib for RET Fusion–Positive NSCLC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 25, 2020

T-DXd for <em>HER2</em>mut NSCLC
Trastuzumab Deruxtecan: An Emerging Option for HER2-Mutated NSCLC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 22, 2020

Activities

NSCLC Biomarkers Guide
Key Clinical Biomarkers for Advanced NSCLC Management: A Resource for Clinicians
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: June 19, 2020

Activities

NSCLC Treatment Tool
Interactive Decision Support Tool: Expert Insight on Therapy Selection for Unresectable Stage III and Metastatic NSCLC
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: January 12, 2021

Expires: January 11, 2022

Faculty

cover img faculity

Edward S. Kim, MD

Chief, Section of Head and Neck Medical Oncology
Associate Professor, Thoracic/Head and Neck Medical Oncology
University of Texas M. D. Anderson Cancer Center
Houston, Texas

cover img faculity

Maria E. Arcila, MD

Associate Attending, Pathology
Diagnostic Molecular Service
Pathology Department
Directory, Diagnostic Molecular Pathology Laboratory
Director, Molecular Hematopathology
Diagnostic Molecular Pathology and Hematopathology
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

Todd M. Bauer, MD

Senior Investigator, Greco-Hainsworth Centers for Research
Tennessee Oncology, PLLC
Nashville, Tennessee

cover img faculity

Lyudmila Bazhenova, MD

Associate Clinical Professor of Medicine
Division of Hematology-Oncology
University of California, San Diego
Medical Director, UC San Diego Moores Cancer Center Infusion Center
San Diego, California

cover img faculity

Matthew Gubens, MD, MS

Associate Professor
Thoracic Oncology
University of California, San Francisco
San Francisco, California

cover img faculity

Leora Horn, MD, MSc

Assistant Professor, Hematology Oncology/Medicine
Vanderbilt Ingram Cancer Center
Vanderbilt University
Nashville, Tennessee

cover img faculity

Wade T. Iams, MD, MSCI

Assistant Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

cover img faculity

Heather J. Jackson, PhD, FNP-BC, NEA-BC, FAANP

Associate Professor
Division of Hematology/Oncology
Department of Medicine
Vanderbilt University School of Nursing
Administrative Director of Advanced Practice
Division of Hematology/Oncology
Department of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

cover img faculity

Eric Q. Konnick, MD, MS

Assistant Professor
Department of Laboratory Medicine
University of Washington
Seattle, Washington

cover img faculity

Nathan Pennell, MD, PhD

Professor
Director,
Cleveland Clinic Lung Cancer Medical Oncology Program
Department of Hematology and Medical Oncology
Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio

cover img faculity

Zofia Piotrowska, MD

Assistant Professor of Medicine
Massachusetts General Hospital Cancer Center
Harvard Medical School
Boston, Massachusetts

cover img faculity

Karen L. Reckamp, MD, MS

Associate Professor
Medical Oncology and Therapeutics Research
City of Hope Comprehensive Cancer Center
Duarte, California

cover img faculity

Laura J. Tafe, MD

Associate Professor of Pathology and Laboratory Medicine
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
The Geisel School of Medicine at Dartmouth
Hanover, New Hampshire

cover img faculity

Vamsidhar Velcheti, MD

Professor of Medicine
NYU Grossman School of Medicine
Medical Director
Thoracic Oncology Program
Laura and Isaac Perlmutter Cancer Center
An NCI-designated Comprehensive Cancer Center
New York, New York 

cover img faculity

H. Jack West, MD

Medical Director
Thoracic Oncology Program
Swedish Cancer Institute
Seattle, Washington

cover img faculity

Helena Yu, MD

Associate Professor
Research Director
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Bristol Myers Squibb

Celgene

Lilly

Loxo Oncology subsidiary of Eli Lilly